Darzalex (daratumumab) 1,800 mg, Janssen Darzalex is used with bortezomib, melphalan and prednisone for certain adults with newly diagnosed multiple myeloma. Contact +380996042415.
Delivery methods
- We can ship by mail to any European country with a delivery time of 8-10 days. Only medications that do not require refrigeration possible shipping. Shipping costs are 40-50 euro, depending on the destination country.
Delivery time
- Originator medicines: 8-10 days
- Generic medicines: 8-10 days
Payment methods
- Bank transfer to the settlement account after receiving the order
Darzalex® is prescribed:
in combination with bortezomib, melphalan and prednisone for the treatment of adult patients with newly diagnosed multiple myeloma who are not candidates for autologous stem cell transplantation;
as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma whose prior therapy included a proteasome inhibitor and an immunomodulatory agent and who had disease progression during the last therapy;
as part of combination therapy with lenalidomide and dexamethasone or bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one line of therapy.
- Trade name:Darzalex
- Chemical name:Daratumumab
- Dosage:1800
- Quantity:1
- Dosage form:Vial
No reviews yet
